tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Max Masucci, 14 are a HOLD (18.42%), 62 are a BUY (81.58%).
Analyst Max Masucci, carries an average stock price target met ratio of 55.66% that have a potential upside of 29.58% achieved within 173 days. Previously, Max Masucci worked at COWEN.
Max Masucci’s has documented 146 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BLFS, BioLife Solutions at 13-Nov-2024.
Analyst best performing recommendations are on BDSX (BIODESIX ).
The best stock recommendation documented was for BDSX (BIODESIX ) at 1/11/2021. The price target of $540 was fulfilled within 4 days with a profit of $89 (19.73%) receiving and performance score of 49.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Mar-2022
$2
$-9.45 (-82.53%)
4 months 29 days ago
(19-Sep-2025)
2/6 (33.33%)
$-5.13 (-71.95%)
1113
Buy Since 23-Nov-2020
$60
8 months 27 days ago
(21-May-2025)
1/2 (50%)
$24.2 (67.60%)
49
Buy Since 23-Nov-2020
$620
3 years 9 months 28 days ago
(20-Apr-2022)
3/5 (60%)
$145.4 (30.64%)
31
Buy Since 23-Nov-2020
$220
$208.55 (1821.40%)
$500
4 years 3 months ago
(17-Nov-2021)
1/3 (33.33%)
$89.4 (68.45%)
38
What Year was the first public recommendation made by Max Masucci?
